IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Third Rock Ventures, LLC

Q1 2014 Holdings

Filed 2014-04-30 | 4 holdings | $218.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Agios Pharmaceuticals, Inc.(AGIO)COM00847X104$217.8M5,564,41499.8%
Foundation Medicine, Inc.COM350465100$212.7K6,569,6450.1%
Eleven Biotherapeutics, Inc.COM286221106$78.6K4,841,5910.0%
bluebird bio, Inc.COM09609G100$55.0K2,416,9740.0%